Intelligence Β· Clinical Pipeline
Sunshine Guojian Pharmaceutical Pipeline
All ClinicalTrials.gov programs at Sunshine Guojian Pharmaceutical β phase, modality, and trial IDs.
- Programs
- 165
Quick answer
Sunshine Guojian Pharmaceutical has 165 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
HEC169584 capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Non - Alcoholic Steatohepatitis
1 trial -
HEC30654AcOH capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hemodialysis
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Kidney Diseases
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
HEC68498
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Refractory Solid Tumors
1 trial -
HEC73077 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Diabetic Nephropathy
1 trial -
HEC74647
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis C
1 trial -
HEC74647PA capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis C
2 trials -
HEC83518
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Insomnia
1 trial -
HEC83518 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Insomnia
1 trial -
HEC89736
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Relapsed or Refractory B-cell Hematologic Malignancies
1 trial -
HEC93077
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout
1 trial -
HEC96719
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Non-alcoholic Fatty Liver Disease
1 trial -
HEC96719
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Nonalcoholic Steatohepatitis (NASH)
1 trial -
HEC96719 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Nonalcoholic Steatohepatitis (NASH)
1 trial -
Humanized TNFΞ± monoclonal antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Insulin degludec injection, RD15003
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes
1 trial -
Kangdaprevir Sodium Tablet
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis c
1 trial -
Larotinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Esophageal Cancer
1 trial -
Larotinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Volunteers
1 trial -
Liraglutide injection,RD12014
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes
1 trial -
Litapiprant Tablet
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Asthma
1 trial -
Midazolam Syrup
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects
1 trial -
PEGylated recombinant candida urate oxidase
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout
1 trial -
Pegylated Recombinant Candida Utilis Uricase for Injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout
1 trial -
Placebo
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
Recombinant erythropoietin stimulating protein
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Renal Failure
1 trial -
Recombinant human thrombopoietin
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Liver Cirrhosis
1 trial -
Rongliflozin
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes Mellitus
1 trial -
SPGL008
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Malignant Tumors
1 trial -
SSGJ-612
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Malignant Tumors
1 trial -
SSGJ-613
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Arthritis, Gouty
1 trial -
SSGJ-613
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Systemic Juvenile Idiopathic Arthritis
1 trial -
SSGJ-705
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Receptor, ErbB-2
1 trial -
SSGJ-706
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Solid Tumors Patients
1 trial -
SSGJ-709
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Malignant Tumors
1 trial -
SSS11
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout
1 trial -
SSS17
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects (HS)
1 trial -
SSS17
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Anemia in Chronic Kidney Diseases
2 trials -
SSS39
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Safety and Tolerability in Healthy Volunteers
1 trial -
SSS55
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Safety Issues
1 trial -
SSS59
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Malignant Tumors
1 trial -
SSS67 Injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
Yimitasvir Phosphate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hepatic Impairment
1 trial -
Yimitasvir Phosphate Capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Impairment
1 trial -
Z650
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Pancreatic Cancer
1 trial -
[14C] Antaitavir Hasophate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Male Subjects
1 trial
Frequently asked questions
How many pipeline programs does Sunshine Guojian Pharmaceutical have?
165 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs